Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 08, 2021 Filed Jun 9, 2021 18:17 UTC |
Euclidean Capital LLC10% owner
Greenland A LLC10% owner
Greenland FP LLC10% owner
Greenland NFP B Ltd.10% owner
Greenland NFP LLC10% owner
Symmetry Group Ltd.10% owner
Simons Marilyn10% owner
Chhabra Ashvin10% owner
SIMONS JAMES H10% owner
|
SaleCommon Stock | 4,708 | $33.38 | $157,153.04 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 7 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 684,497 F2 · ownership.nature: 2. The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 08, 2021 Filed Jun 9, 2021 18:17 UTC |
Euclidean Capital LLC10% owner
Greenland A LLC10% owner
Greenland FP LLC10% owner
Greenland NFP B Ltd.10% owner
Greenland NFP LLC10% owner
Symmetry Group Ltd.10% owner
Simons Marilyn10% owner
Chhabra Ashvin10% owner
SIMONS JAMES H10% owner
|
SaleCommon Stock | 3,355 | $33.38 | $111,989.90 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 6 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 487,761 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 23:22 UTC |
Alland LeilaChief Medical Officer
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $3.90 | $0.00 |
DisclosureSEC source: 0001209191-21-039035 · doc4.xml · derivative · entry 5 Alland Leila · CIK 0001825216 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 365,850 Underlying: Common Stock · 4,000 shares Expires 2030-02-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: One-fourth of the shares subject to the option vested on December 3, 2020, and one forty-eighth of the shares subject to the option shall vest each month thereafter. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 23:22 UTC |
Alland LeilaChief Medical Officer
|
SaleCommon Stock | 1,367 | $34.00 | $46,483.60 |
DisclosureSEC source: 0001209191-21-039035 · doc4.xml · nonDerivative · entry 3 Alland Leila · CIK 0001825216 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F3 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.705 to $34.255, inclusive. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 23:22 UTC |
Alland LeilaChief Medical Officer
|
SaleCommon Stock | 2,633 | $33.39 | $87,903.23 |
DisclosureSEC source: 0001209191-21-039035 · doc4.xml · nonDerivative · entry 2 Alland Leila · CIK 0001825216 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,367 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F2 · shares: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.705 to $33.66, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| June 07, 2021 Filed Jun 8, 2021 23:22 UTC |
Alland LeilaChief Medical Officer
|
Exercise / conversionCommon Stock | 4,000 | $3.90 | $15,600.00 |
DisclosureSEC source: 0001209191-21-039035 · doc4.xml · nonDerivative · entry 1 Alland Leila · CIK 0001825216 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC |
Euclidean Capital LLC10% owner
Greenland A LLC10% owner
Greenland FP LLC10% owner
Greenland NFP B Ltd.10% owner
Greenland NFP LLC10% owner
Symmetry Group Ltd.10% owner
Simons Marilyn10% owner
Chhabra Ashvin10% owner
SIMONS JAMES H10% owner
|
SaleCommon Stock | 1,019 | $33.62 | $34,258.78 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 5 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 131,582 F5 · ownership.nature: The shares are held of record by Greenland NFP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC |
Euclidean Capital LLC10% owner
Greenland A LLC10% owner
Greenland FP LLC10% owner
Greenland NFP B Ltd.10% owner
Greenland NFP LLC10% owner
Symmetry Group Ltd.10% owner
Simons Marilyn10% owner
Chhabra Ashvin10% owner
SIMONS JAMES H10% owner
|
SaleCommon Stock | 16,901 | $33.62 | $568,211.62 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 4 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 2,584,736 F4 · ownership.nature: The shares are held of record by Greenland NFP B Ltd., which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC |
Euclidean Capital LLC10% owner
Greenland A LLC10% owner
Greenland FP LLC10% owner
Greenland NFP B Ltd.10% owner
Greenland NFP LLC10% owner
Symmetry Group Ltd.10% owner
Simons Marilyn10% owner
Chhabra Ashvin10% owner
SIMONS JAMES H10% owner
|
SaleCommon Stock | 4,946 | $33.62 | $166,284.52 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 3 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 746,463 F3 · ownership.nature: The shares are held of record by Greenland FP LLC, which is managed by Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC |
Euclidean Capital LLC10% owner
Greenland A LLC10% owner
Greenland FP LLC10% owner
Greenland NFP B Ltd.10% owner
Greenland NFP LLC10% owner
Symmetry Group Ltd.10% owner
Simons Marilyn10% owner
Chhabra Ashvin10% owner
SIMONS JAMES H10% owner
|
SaleCommon Stock | 4,564 | $33.62 | $153,441.68 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 2 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 689,205 F2 · ownership.nature: 2. The shares are held of record by Greenland A LLC, which is managed by Euclidean Capital LLC ("Euclidean"). Mrs. Simons and Mr. Simons are owners and managers of Euclidean, and Ashvin Chhabra is President, CIO and Manager of Euclidean. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 07, 2021 Filed Jun 9, 2021 18:17 UTC |
Euclidean Capital LLC10% owner
Greenland A LLC10% owner
Greenland FP LLC10% owner
Greenland NFP B Ltd.10% owner
Greenland NFP LLC10% owner
Symmetry Group Ltd.10% owner
Simons Marilyn10% owner
Chhabra Ashvin10% owner
SIMONS JAMES H10% owner
|
SaleCommon Stock | 3,291 | $33.62 | $110,643.42 |
DisclosureSEC source: 0001062993-21-005496 · form4.xml · nonDerivative · entry 1 Euclidean Capital LLC · CIK 0001825034 · 10% owner Greenland A LLC · CIK 0001825026 · 10% owner Greenland FP LLC · CIK 0001825227 · 10% owner Greenland NFP B Ltd. · CIK 0001825238 · 10% owner Greenland NFP LLC · CIK 0001825241 · 10% owner Symmetry Group Ltd. · CIK 0001861029 · 10% owner Simons Marilyn · CIK 0001825290 · 10% owner Chhabra Ashvin · CIK 0001825293 · 10% owner SIMONS JAMES H · CIK 0000941976 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 491,116 F1 · ownership.nature: The shares are held of record by Symmetry Group Ltd ("Symmetry"). Marilyn Simons and James Simons are on the board of directors of Symmetry's parent. F6 · ownership.nature: Each of the Reporting Persons disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of the securities reported on this Form 4, except to the extent of any pecuniary interest therein. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 21:36 UTC |
Kung WinstonCOO, CFO
|
Exercise / conversionStock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $3.22 | $0.00 |
DisclosureSEC source: 0001209191-21-038798 · doc4.xml · derivative · entry 3 Kung Winston · CIK 0001666963 · COO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 228,034 Underlying: Common Stock · 4,500 shares Expires 2028-02-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: The option is subject to an early exercise provision and is immediately exercisable. The underlying shares vest in accordance with the terms of the option grant. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 21:36 UTC |
Kung WinstonCOO, CFO
|
SaleCommon Stock | 4,500 | $33.75 | $151,875.00 |
DisclosureSEC source: 0001209191-21-038798 · doc4.xml · nonDerivative · entry 2 Kung Winston · CIK 0001666963 · COO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,600 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. Read SEC document |
| June 04, 2021 Filed Jun 7, 2021 21:36 UTC |
Kung WinstonCOO, CFO
|
Exercise / conversionCommon Stock | 4,500 | $3.22 | $14,490.00 |
DisclosureSEC source: 0001209191-21-038798 · doc4.xml · nonDerivative · entry 1 Kung Winston · CIK 0001666963 · COO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,100 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 02, 2021 Filed Jun 9, 2021 21:33 UTC |
LEVINE ARNOLD JDirector
|
GrantStock option (right to buy) · Derivative | 16,333 | $0.00 Strike: $32.29 | $0.00 |
DisclosureSEC source: 0001209191-21-039239 · doc4.xml · derivative · entry 1 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,333 Underlying: Common Stock · 16,333 shares Expires 2031-06-01 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 2, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 02, 2021 Filed Jun 9, 2021 21:28 UTC |
BAUM CHARLES MDirector
|
GrantStock Option (right to buy) · Derivative | 16,333 | $0.00 Strike: $32.29 | $0.00 |
DisclosureSEC source: 0001209191-21-039235 · doc4.xml · derivative · entry 1 BAUM CHARLES M · CIK 0001579824 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,333 Underlying: Common Stock · 16,333 shares Expires 2031-06-01 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 2, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 02, 2021 Filed Jun 9, 2021 21:30 UTC |
Heyman Richard A.Director
|
GrantStock Option (right to buy) · Derivative | 16,333 | $0.00 Strike: $32.29 | $0.00 |
DisclosureSEC source: 0001209191-21-039237 · doc4.xml · derivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,333 Underlying: Common Stock · 16,333 shares Expires 2031-06-01 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 2, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 02, 2021 Filed Jun 9, 2021 21:39 UTC |
Stelzer LaurieDirector
|
GrantStock Option · Derivative | 16,333 | $0.00 Strike: $32.29 | $0.00 |
DisclosureSEC source: 0001209191-21-039241 · doc4.xml · derivative · entry 1 Stelzer Laurie · CIK 0001644348 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,333 Underlying: Common Stock · 16,333 shares Expires 2031-06-01 F1 · derivative.exercise_date: Shares subject to the option vest on the earlier of (i) June 2, 2022 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 975 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · derivative · entry 15 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,951 Underlying: Common Stock · 975 shares Expires 2027-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: All of the shares subject to the option are vested and immediately exercisable. F8 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 975 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · derivative · entry 14 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 7,951 Underlying: Common Stock · 975 shares Expires 2027-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: All of the shares subject to the option are vested and immediately exercisable. F5 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
Exercise / conversionStock Option (right to buy) · Derivative | 1,950 | $0.00 Strike: $2.95 | $0.00 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · derivative · entry 13 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 15,901 Underlying: Common Stock · 1,950 shares Expires 2027-08-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F11 · derivative.exercise_date: All of the shares subject to the option are vested and immediately exercisable. F1 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 2 | $34.67 | $69.34 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 12 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F8 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 209 | $33.79 | $7,061.73 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 11 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F10 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive. F8 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 764 | $32.15 | $24,563.13 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 10 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 211 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F9 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.00 to $32.815, inclusive. F8 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
Exercise / conversionCommon Stock | 975 | $975.00 | $950,625.00 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 9 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Scott Z. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's son and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 2 | $34.67 | $69.34 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 8 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F5 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 230 | $33.75 | $7,761.70 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 7 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F7 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.62 to $33.875, inclusive. F5 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 743 | $32.16 | $23,896.22 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 6 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 232 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F6 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.02 to $32.46, inclusive. F5 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
Exercise / conversionCommon Stock | 975 | $2.95 | $2,876.25 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 5 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Julia E. Heyman 2016 Irrevocable Trust under agreement dated November 1, 2016 for the benefit of the Reporting Person's daughter and descendants. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 5 | $34.67 | $173.35 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 4 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 0 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F1 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 553 | $33.61 | $18,586.61 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 3 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 5 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.055 to $33.875, inclusive. F1 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
SaleCommon Stock | 1,392 | $32.15 | $44,754.05 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 2 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 558 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 30, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.01 to $32.815, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2), (4), (6), (7), (9) and (10) to this Form 4. F1 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family. Read SEC document |
| June 01, 2021 Filed Jun 2, 2021 20:11 UTC |
Heyman Richard A.Director
|
Exercise / conversionCommon Stock | 1,950 | $2.95 | $5,752.50 |
DisclosureSEC source: 0001209191-21-037144 · doc4.xml · nonDerivative · entry 1 Heyman Richard A. · CIK 0001584759 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 1,950 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · ownership.nature: The shares are held of record by Paul L. Vogel as Trustee of the Heyman Family 2020 Irrevocable Trust under agreement dated August 31, 2020 for the benefit of the Reporting Person's immediate family. Read SEC document |
| May 28, 2021 Filed Jun 2, 2021 22:07 UTC |
Schroeder ThiloDirector
|
SaleCommon Stock | 5,100 | $35.80 | $182,580.00 |
DisclosureSEC source: 0001209191-21-037377 · doc4.xml · nonDerivative · entry 1 Schroeder Thilo · CIK 0001776412 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,038,529 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.61 to 36.51 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 26, 2021 Filed May 27, 2021 23:41 UTC |
Schroeder ThiloDirector
|
SaleCommon Stock | 7,487 | $35.66 | $266,986.42 |
DisclosureSEC source: 0001209191-21-036352 · doc4.xml · nonDerivative · entry 2 Schroeder Thilo · CIK 0001776412 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,043,629 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.60 to $35.91 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 25, 2021 Filed May 27, 2021 23:41 UTC |
Schroeder ThiloDirector
|
SaleCommon Stock | 8,518 | $35.91 | $305,881.38 |
DisclosureSEC source: 0001209191-21-036352 · doc4.xml · nonDerivative · entry 1 Schroeder Thilo · CIK 0001776412 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,051,116 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.66 to 36.32 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 24, 2021 Filed May 24, 2021 23:59 UTC |
Schroeder ThiloDirector
|
SaleCommon Stock | 22,095 | $36.03 | $796,082.85 |
DisclosureSEC source: 0001209191-21-035544 · doc4.xml · nonDerivative · entry 3 Schroeder Thilo · CIK 0001776412 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,059,634 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.61 to $36.29 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 21, 2021 Filed May 24, 2021 16:52 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 6,207 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001209191-21-035364 · doc4.xml · derivative · entry 8 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 485,074 Underlying: Common Stock · 6,207 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| May 21, 2021 Filed May 24, 2021 16:52 UTC |
Mack David HenryDirector · President and CEO
|
SaleCommon Stock | 6,207 | $35.71 | $221,641.42 |
DisclosureSEC source: 0001209191-21-035364 · doc4.xml · nonDerivative · entry 4 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,470 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.99, inclusive. Read SEC document |
| May 21, 2021 Filed May 24, 2021 16:52 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionCommon Stock | 6,207 | $0.53 | $3,289.71 |
DisclosureSEC source: 0001209191-21-035364 · doc4.xml · nonDerivative · entry 3 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,677 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 21, 2021 Filed May 24, 2021 23:59 UTC |
Schroeder ThiloDirector
|
SaleCommon Stock | 19,774 | $35.84 | $708,700.16 |
DisclosureSEC source: 0001209191-21-035544 · doc4.xml · nonDerivative · entry 2 Schroeder Thilo · CIK 0001776412 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,081,729 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.60 to $36.20 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 21, 2021 Filed Jun 4, 2021 19:13 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 10,000 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001209191-21-038419 · doc4.xml · derivative · entry 4 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 475,074 Underlying: Common Stock · 10,000 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:38 UTC |
LEVINE ARNOLD JDirector
|
SaleCommon Stock | 2,961 | $34.68 | $102,675.64 |
DisclosureSEC source: 0001209191-21-035034 · doc4.xml · nonDerivative · entry 2 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 423,842 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.22 to $35.145, inclusive. Read SEC document |
| May 20, 2021 Filed May 21, 2021 21:38 UTC |
LEVINE ARNOLD JDirector
|
SaleCommon Stock | 539 | $33.57 | $18,092.29 |
DisclosureSEC source: 0001209191-21-035034 · doc4.xml · nonDerivative · entry 1 LEVINE ARNOLD J · CIK 0001124164 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,803 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 27, 2021. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $33.22 to $34.215, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| May 20, 2021 Filed May 24, 2021 16:52 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,793 | $0.00 Strike: $0.53 | $0.00 |
DisclosureSEC source: 0001209191-21-035364 · doc4.xml · derivative · entry 7 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 492,867 Underlying: Common Stock · 7,793 shares Expires 2025-05-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The shares subject to the option are fully vested and immediately exercisable. Read SEC document |
| May 20, 2021 Filed May 24, 2021 16:52 UTC |
Mack David HenryDirector · President and CEO
|
SaleCommon Stock | 7,793 | $35.60 | $277,454.96 |
DisclosureSEC source: 0001209191-21-035364 · doc4.xml · nonDerivative · entry 2 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,470 F1 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 29, 2020. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.53 to $35.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3) to this Form 4. Read SEC document |
| May 20, 2021 Filed May 24, 2021 16:52 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionCommon Stock | 7,793 | $0.53 | $4,130.29 |
DisclosureSEC source: 0001209191-21-035364 · doc4.xml · nonDerivative · entry 1 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,263 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 20, 2021 Filed May 24, 2021 23:59 UTC |
Schroeder ThiloDirector
|
SaleCommon Stock | 2,911 | $35.65 | $103,777.15 |
DisclosureSEC source: 0001209191-21-035544 · doc4.xml · nonDerivative · entry 1 Schroeder Thilo · CIK 0001776412 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · See footnote Disclosed balance after: 2,101,503 F1 · kind: Shares were sold pursuant to a Rule 10b5-1 trading plan. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.61 to 35.77 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. F3 · ownership.nature: The shares are held of record by Nextech V Oncology S.C.S., SICAV-SIF. The Reporting Person is a partner at Nextech Invest AG and in the Investment Committee of Nextech Invest AG, with significant influence over Nextech V Oncology S.C.S., SICAV-SIF in terms of investment decisions, selling strategy of shares and voting power and as a result, may be deemed to have beneficial ownership over such securities. The Reporting Person disclaims beneficial ownership over the shares reported herein except to the extent of his pecuniary interest therein, if any. Read SEC document |
| May 20, 2021 Filed Jun 4, 2021 19:13 UTC |
Mack David HenryDirector · President and CEO
|
Exercise / conversionCommon Stock | 10,000 | $0.53 | $5,300.00 |
DisclosureSEC source: 0001209191-21-038419 · doc4.xml · nonDerivative · entry 1 Mack David Henry · CIK 0001341642 · Director · President and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,470 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 12, 2021 Filed Jun 8, 2021 19:17 UTC |
Kung WinstonCOO, CFO
|
GrantEmployee Stock Option (right to buy) · Derivative | 50,337 | $0.00 Strike: $28.33 | $0.00 |
DisclosureSEC source: 0001209191-21-039032 · doc4.xml · derivative · entry 1 Kung Winston · CIK 0001666963 · COO, CFO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,337 Underlying: Common Stock · 50,337 shares Expires 2031-05-11 F1 · derivative.exercise_date: Shares subject to the option vest in 48 equal monthly installments beginning on June 12, 2021. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.